Far Infrared Radiation for Sickle Cell Pain Management

GAAD Medical Research Institute Inc.

Status and phase: Unknown; Phase 1

Conditions: Anemia, Sickle Cell

Treatments: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Study type: Interventional

Funder types: Other

Identifiers

NCT00599482

GAAD-SCC-CTP1

Details and patient eligibility

About

Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.

Full description

Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue.

It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.

Enrollment: 10 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• People with sickle cell disease

Exclusion criteria

• None

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

1

Other group

Description:

Far Infrared Radiation

Treatment:

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)